LSO Medical Announces CE Approval of Next-Gen LUMESEAL Laser for Treatment of Varicose Vein.

LUMESEAL® Adds SnakeBack® to Enhance Ease-of-Use and Control "The integration of SnakeBack® technology on LUMESEAL® is a big step forward for the development of the technique. Beyond its direct impact on enhancing the reproducibility and comfort of laser delivery, the LUMESEAL®  platform allows us to assess further improvements in the EVLT technique (new wavelengths, applicators,...) "says M. Rochon, LSO Medical CEO. Limited commercial release due to the international shortage around the...

"The integration of SnakeBack® technology on LUMESEAL® is a big step forward for the development of the technique. Beyond its direct impact on enhancing the reproducibility and comfort of laser delivery, the LUMESEAL®  platform allows us to assess further improvements in the EVLT technique (new wavelengths, applicators, ...) "says M. Rochon, LSO Medical CEO.

Limited commercial release due to the international shortage around the semiconductor is planned for the fall with a full launch anticipated in early 2022.

About LSO Medical

With more than 20 years' experience, the French company LSO Medical is a key player in the design, production and marketing of innovativemedical laser systems.

Constantly aiming at exploiting and bringing technological innovations to doctors and their patients, LSO Medical is today one of the world leaders in the endothermic laser technique.

Contact

To learn more about the laser LUMESEAL® and/or the SnakeBack® technology: [email protected]

Logo - https://mma.prnewswire.com/media/1630879/LSO_Medical_Logo.jpg